| | | | |  | | By Jake Sherman, Anna Palmer, Garrett Ross and Eli Okun | Presented by |  | | | PRESIDENT DONALD TRUMP ALLOWED an unvarnished and candid peek into his mind in the middle of this global public health crisis, unfurling an angry tirade at a political group seeking to push him out of the White House, musing aloud that a pair of female reporters were not like a television actress who played a housewife and contradicting his own White House's explanation for why ANTHONY FAUCI could not testify to the House. NOT ONLY did the president lambast his rivals, he also managed to elevate them and their causes in the same breath. IN AN INTERVIEW WITH THE NEW YORK POST, the president said that CBS reporters PAULA REID and WEIJIA JIANG were not Donna Reed -- the actress who played Mary Bailey in "It's a Wonderful Life" and later a housewife in "The Donna Reed Show." REID and JIANG have both drawn TRUMP'S ire for tough questioning. JUST AFTER MIDNIGHT, the president tweeted four times about the LINCOLN PROJECT, a GOP political group with designs on defeating him. The LINCOLN PROJECT has $1.2 million in its coffers, roughly 1% of the president's kitty. The group has been running ads on Fox News. In the last day, THE PRESIDENT has also taken aim at MSNBC's "MORNING JOE," while touting the ratings his news conferences have gotten. BEFORE BOARDING A HELICOPTER EN ROUTE to Phoenix, TRUMP told reporters that he would not permit FAUCI -- the administration's most recognizable infectious disease expert -- to testify because the Democratic House was filled with "a bunch of Trump haters" who "want our situation to be unsuccessful, which means death." (It's not clear the juice is worth the squeeze here, since FAUCI will have to face Democrats in the House and Senate.) THE WHITE HOUSE has spun a different narrative publicly about why FAUCI won't testify. Last week, they said task force members were simply too busy to come to Capitol Hill in the middle of the pandemic. BUT PRIVATELY, HOUSE DEMOCRATS thought they had a chance to land FAUCI. Last Monday, the Appropriations Committee reached out to the NIH to inquire about the doctor's availability. A Democratic aide said the NIH seemed interested, even asking what social distancing measures the committee was taking. LAST TUESDAY, however, Democrats' outlook turned darker when the Appropriations Committee heard that the White House was reviewing requests for testimony. The committee reached out to the administration to see if Chairwoman NITA LOWEY (D-N.Y.) and White House chief of staff MARK MEADOWS could talk. ON WEDNESDAY NIGHT, LOWEY and MEADOWS spoke on the phone several times, as the chief of staff pushed for more details about the hearing -- the committee says he wanted to clear individual questions, but the White House says he wanted to know more details about the topic of the hearing. THEY SPOKE FOR THE LAST TIME at 10:46 p.m. They resolved to speak the next day, but didn't. On Friday morning, NIH Director FRANCIS COLLINS told Rep. ROSA DELAURO (D-Conn.) -- who has purview over NIH -- that FAUCI would be testifying in front of the Senate, not the House. The Democrats then went public with their complaint that FAUCI was not being made available. The White House said they were not acting in good faith. Although TRUMP is now saying the House is "a bunch of Trump haters." SPEAKER NANCY PELOSI responded to Trump's remark with a summary dismissal: "It's not worth getting into," she said, per a pool report by WaPo's MIKE DEBONIS. FAUCI will testify in front of Senate HELP on May 12. Good Tuesday afternoon. | | A message from Google: Helping small businesses adapt with tools and training. Small businesses across the country are facing unique challenges. Google is helping with free resources like online workshops, one-on-one coaching sessions, and short video tutorials to help small businesses adjust, whether they're working from home or operating a business online. Learn more. | | | YOWZA … WAPO: "Kushner coronavirus effort said to be hampered by inexperienced volunteers," by Yasmeen Abutaleb and Ashley Parker: "The coronavirus response being spearheaded by President Trump's son-in-law, Jared Kushner, has relied in part on volunteers from consulting and private equity firms with little expertise in the tasks to which they were assigned, exacerbating chronic problems in obtaining supplies for hospitals and other needs, according to numerous government officials and a volunteer involved in the effort. … "Although some of the volunteers have relevant backgrounds and experience, many others were poorly matched with the jobs they were assigned, including those given the task of securing personal protective equipment, or PPE, for hospitals nationwide, according to a complaint filed last month with the House Oversight Committee. … "The document alleges that the team responsible for PPE had little success in helping the government secure such equipment, in part because none of the team's members had significant experience in health care, procurement or supply-chain operations. In addition, none of the volunteers had existing relationships with manufacturers or a clear understanding of customs requirements or Food and Drug Administration rules, according to the complaint and two senior administration officials. … "Supply-chain volunteers were instructed to fast-track protective equipment leads from 'VIPs,' including conservative journalists friendly to the White House, according to the complaint and one senior administration official. 'Fox & Friends' host Brian Kilmeade, for example, called two people he knew in the administration to pass along a lead about protective equipment in an effort to be helpful, according to two people familiar with the outreach. Fox News Channel host Jeanine Pirro also repeatedly lobbied the administration for a specific New York hospital to receive a large quantity of masks, one of the people said. "Kilmeade and Pirro said they were not aware that their tips were being prioritized, a Fox News spokeswoman said." HOUSE MAJORITY LEADER STENY HOYER confirmed HEATHER CAYGLE and SARAH FERRIS' story from this morning -- that the House would move without Republicans to pass their own CARES package next week. This is a signal that the eventual package is a while away. -- HOYER REPLIES TO KEVIN MCCARTHY on his fixes for House operations: Thanks, but we're good. RATCLIFFE TESTIFIES -- "Ratcliffe sheds hard-line posture with vows to be independent intel chief," by Andrew Desiderio and Martin Matishak: "President Donald Trump's pick to lead the nation's 17 intelligence agencies repeatedly vowed on Tuesday to be independent, breaking with the president's long-held view that the clandestine community has 'run amok' and demurring on Trump's suggestions that there is a 'deep state' trying to undermine his agenda. "Rep. John Ratcliffe (R-Texas), a steadfast Trump ally vying to be the director of national intelligence, told members of the Senate Intelligence Committee in his confirmation hearing that he would provide the president and members of Congress with 'timely, accurate and objective intelligence.' "'Let me be very clear: Regardless of what anyone wants our intelligence to reflect, the intelligence I provide, if confirmed, will not be impacted or altered as a result of outside influence,' Ratcliffe said, adding that he would provide intelligence briefings to the president even if he knew Trump would disagree with the conclusions, or if he believed his job were at risk for doing so. "'Anyone's views on what they want the intelligence to be will never impact the intelligence that I deliver — never,' Ratcliffe pledged under intense questioning by Sen. Susan Collins (R-Maine). 'I won't shade intelligence for anyone.'" POLITICO -- SEN. RICHARD BURR (R-N.C.) -- the Intel chairman -- said he planned to move RATCLIFFE'S nomination through his committee next week, per DEBONIS' pool report. | | | | POLITICO Magazine Justice Reform: The Decarceration Issue, presented by Verizon: Over the past decade, the long-standing challenge of criminal-justice reform has emerged under the spotlight with a new twist: Both Republicans and Democrats are on board. But if both parties want to lower the incarceration rate, why are our jail and prison populations still so high? The latest series from POLITICO Magazine works to answer this important question and take a deeper look into what it will take to make progress in the policy and politics of justice reform. READ THE FULL ISSUE. | | | | | THE MILITARY'S REALITY … WSJ'S NANCY YOUSSEF in Fort Polk, La.: "Army's New Mission: Train for War, Avoid Coronavirus": "When the Army's Fourth Security Force Assistance Brigade arrives at this base in southwestern Louisiana next month for training to go to Afghanistan, the troops will gather where warfighting and coronavirus collide. "A barracks that normally bunks 44 soldiers instead will hold only 12, in cots spaced 6 feet apart. When waiting in line at an assembly building, troops must stand in prespaced squares, painted red. Masks, gloves and eye protection will be required. So will temperature checks, quarantines and social distancing. "'We're looking at the long game. We're not waiting for Covid-19 to go away,' said Gen. James McConville, chief of staff of the Army, who visited the training site last week. "The Army will face the same uncertainties that confront the rest of the world as it plots how to cope with the pandemic: the possibility of infection, the need for vigilant prevention and a shortage of virus-testing supplies. But Gen. McConville said the Army must move ahead with training and deployment." THE VACCINE RACE -- "Pfizer Begins Human Trials of Possible Coronavirus Vaccine," by NYT's Knvul Sheikh: "Pfizer and the German pharmaceutical company BioNTech announced that their potential coronavirus vaccine began human trials in the United States on Monday. If the tests are successful, the vaccine could be ready for emergency use here as early as September. … "Pfizer, which is based in New York, and BioNTech injected the first human volunteers with their vaccine candidate, called BNT162, in Germany last month. The experimental shot was given to just 12 healthy adults, although the trial will eventually expand to 200 participants. In the United States, the drug companies plan to test the vaccine on 360 healthy volunteers for the first stage of the study, adding up to 8,000 volunteers by the end of the second stage." NYT THE LATEST IN NEW YORK -- "Another 1,700 virus deaths reported in N.Y. nursing homes," by AP's Marina Villeneuve in Albany, N.Y.: "At least 4,813 people have died from COVID-19 in the state's nursing homes since March 1, according to a tally released by Gov. Andrew Cuomo's administration late Monday that, for the first time, includes people believed to have been killed by the coronavirus before their diagnoses could be confirmed by a lab test." AP -- "De Blasio, NYC health officials warn of rare children's disease with potential links to coronavirus," by Amanda Eisenberg and Erin Durkin: "City leaders raised alarms Tuesday about a rare illness among children that is potentially associated with coronavirus, after fifteen kids were admitted to New York City's pediatric intensive care units showing symptoms. "The city health department issued guidance on the condition Monday night. The kids, ages 2 to 15, reported illnesses compatible with multi-system inflammatory syndrome — which have also been reported in young people in the U.K. and some European countries. The symptoms are in line with Kawasaki disease, a rare disorder that inflames the blood vessels and could cause swelling in the hands and feet, among other issues." POLITICO New York HMM -- "U.S. companies cut thousands of workers while continuing to reward shareholders during pandemic," by WaPo's Peter Whoriskey: "Since the coronavirus pandemic was declared, Caterpillar has suspended operations at two plants and a foundry, Levi Strauss has closed stores and toolmaker Stanley Black & Decker is planning layoffs and furloughs. Steelcase, the office furniture manufacturer, and World Wrestling Entertainment have also both shed employees. "While thousands of their workers are filing for unemployment benefits, these companies rewarded their shareholders with more than $700 million in cash dividends. They are not alone. As the pandemic squeezes big companies, executives are making decisions about who will bear the brunt of the sacrifices, and in at least some cases, workers have been the first to lose, even as shareholders continue to collect." WaPo | | | | TOMORROW - HOW DO WE SAVE SMALL BUSINESSES? The coronavirus has crushed small businesses across the country. There's been confusion and frustration stemming from the turbulent rollout of the Paycheck Protection Program. Join POLITICO chief economic correspondent Ben White tomorrow at 9 a.m. EDT for a virtual discussion with Sen. Ben Cardin of Maryland, the ranking Democrat on the Senate Small Business Committee, about how banks have struggled with the Paycheck Protection Program's disbursement process, what the next round of stimulus funding must include to keep small businesses and local economies afloat, and the return of elected officials to the Capitol despite concerns about spurring an outbreak. Have questions? Submit yours by tweeting it to @POLITICOLive using #AskPOLITICO. REGISTER HERE. | | | | | THE ECONOMY -- "U.S. March Trade Deficit Widened as Coronavirus Disruptions Spread," by WSJ's David Harrison: "The deficit rose 11.6% to a seasonally adjusted $44.4 billion in March from $39.8 billion in February, snapping two months of declines, the Commerce Department said Tuesday. Imports declined 6.2% to $232.2 billion in March, the lowest figure since October 2016. Exports were down 9.6% to $187.7 billion, lowest since November 2016." WSJ -- "Why Home Prices Are Rising During the Pandemic," by WSJ's Nicole Friedman: "The economy is shrinking, businesses are closing and jobs are disappearing due to the coronavirus pandemic. But in the housing market, prices keep chugging higher. Home prices plunged during the last recession after a housing crash caused millions of families to lose their homes. Home values could start to erode again, especially when mortgage forbearances end, some economists warn. "But that hasn't been the case so far. The median home price rose 8% year-over-year to $280,600 in March, according to the National Association of Realtors. While buyer demand has softened and sales fell 8.5% that month from the prior month, the supply of homes on the market is contracting even faster, recent preliminary data shows. … What's more, many sellers have been reluctant to cut prices." WSJ THE REOPENING -- "Detroit automakers push for restart of plants within 2 weeks," by AP's Tom Krisher and Colleen Barry in Detroit: "Major U.S. automakers are planning to reopen North American factories within two weeks, potentially putting thousands of workers back on the assembly line as part of a gradual return to normality. "Fiat Chrysler CEO Mike Manley said on an earnings conference call Tuesday his company plans to start reopening factories May 18, though that depends on an easing of government restrictions. Right now, Michigan's shelter-at-home order is in effect until May 15. Detroit automakers will likely be on the same timetable because their workers are represented by the same union. The United Auto Workers union on Tuesday appeared to be onboard." AP DRUG DANGERS -- "This Drug May Cause Birth Defects. Japan's Pushing It for Coronavirus," by NYT's Ben Dooley in Tokyo: "[Japanese PM Shinzo] Abe has pushed the homegrown drug in news conferences and in meetings with world leaders, including a call with Mr. Trump and the other heads of the Group of 7. He has allocated nearly $130 million to triple an existing stockpile of the medication. And he has offered to provide it free to dozens of other countries. "The prime minister, however, has glossed over one crucial fact: There is no solid evidence that Avigan is actually effective against Covid-19. While the drug has shown potential for treating some deadly diseases like Ebola in animal studies, there are limited findings that it works for any illness in humans. What Avigan, whose generic name is favipiravir, does have is a peculiar regulatory history and one dangerous potential side effect — birth defects." NYT MEDIAWATCH -- Mark Schoofs is rejoining BuzzFeed as editor-in-chief, replacing Ben Smith. He currently is a visiting professor at the USC Annenberg School for Communication and Journalism. -- "Danielle Carrig Exits Vice Media Group to Join Condé Nast as Communications Chief," by Variety's Todd Spangler TRANSITIONS -- "Key FEMA Leader to Depart Amid Coronavirus Effort," by WSJ's Rachael Levy: "Josh Dozor, who is deputy assistant administrator for FEMA's response group, told colleagues he plans to leave in the coming weeks for personal reasons, according to these people. Mr. Dozor was involved in early discussions with the Department of Health and Human Services in coordinating the government's response to the new coronavirus before FEMA became the lead agency in mid-March." WSJ -- Meredith Scialabba is now a senior director for financial services public affairs at FTI Consulting. She previously was a public affairs strategist at the CFTC. BONUS BIRTHDAY: Former Rep. Charlie Gonzalez (D-Texas) is 75 (h/t John Barrow) | | | | A message from Google:   Grow with Google is offering online workshops and virtual one-on-one coaching sessions to help people stay connected and productive while working remotely. Learn more. | | | | | | | Follow us on Twitter | | | | Subscribe to the POLITICO Playbook family Playbook | Playbook PM | California Playbook | Florida Playbook | Illinois Playbook | Massachusetts Playbook | New Jersey Playbook | New York Playbook | Brussels Playbook | London Playbook View all our politics and policy newsletters | | Follow us | | | | |
